• COSELA™ (trilaciclib) Kickoff Analyst and Investor Summit hosted by G1 Therapeutics

    • Share:
    Name: COSELA™ (trilaciclib) Kickoff Analyst and Investor Summit hosted by G1 Therapeutics
    Date: April 9, 2021
    Time: 9:00 AM - 11:00 AM EDT
    Website: Watch here!
    Event Description:
    G1 Therapeutics will review its U.S. launch strategy for the first-in-class myeloprotection therapy, COSELA, in extensive-stage small cell lung cancer. COSELA is the only FDA-approved therapy that helps proactively deliver multilineage myeloprotection benefit to patients with extensive-stage small cell lung cancer being treated with chemotherapy. The program will also feature insights about the urgent need to proactively treat patients for myelosuppression from the following leading clinicians:
    • Jared Weiss, M.D., Thoracic and Head/Neck Oncologist & Associate Professor, Division of Oncology, University of North Carolina at Chapel Hill
    • Tajuana Bradley, MS, FNP-BC, Nurse Practitioner, Georgia Cancer Specialists
    Location:
    Virtual
    Date/Time Information:
    April 9
    9 - 11 a.m.
    Fees/Admission:
    A webcast of the event can be accessed on the Events & Presentations page of www.g1therapeutics.com. The webcast will be archived on the same page for 90 days following the event.
    Set a Reminder:
    Enter your email address below to receive a reminder message.
  • NCBIO Events

  • Latest Tweets